Amryt Pharma plc

Amryt Pharma plcverified

AMYT

Price:

$14.7

Market Cap:

$0

Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-07-08

Stock Exchange

NASDAQ

Ticker

AMYT

The Enterprise Value as of May 2024 (TTM) for Amryt Pharma plc (AMYT) is 86.41M

According to Amryt Pharma plc’s latest financial reports and current stock price. The company's current Enterprise Value is 86.41M. This represents a change of -69.89% compared to the average of 286.97M of the last 4 quarters.

Amryt Pharma plc (AMYT) Historical Enterprise Value (quarterly & annually)

How has AMYT Enterprise Value performed in the past?

The mean historical Enterprise Value of Amryt Pharma plc over the last ten years is 172.31M. The current 86.41M Enterprise Value has changed 4.91% with respect to the historical average. Over the past ten years (40 quarters), AMYT's Enterprise Value was at its highest in in the September 2021 quarter at 850.44M. The Enterprise Value was at its lowest in in the March 2013 quarter at -31506016.00.

Quarterly (TTM)
Annual

Average

172.31M

Median

64.17M

Minimum

8.44M

Maximum

595.85M

Amryt Pharma plc (AMYT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amryt Pharma plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 363.21%

Maximum Annual Enterprise Value = 595.85M

Minimum Annual Increase = -85.97%

Minimum Annual Enterprise Value = 8.44M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2021595.85M3.41%
2020576.18M146.33%
2019233.90M228.22%
201871.26M90.78%
201737.35M14.24%
201632.70M-52.05%
201568.19M74.44%
201439.09M363.21%
20138.44M-85.97%
201260.15M6.43%

Amryt Pharma plc (AMYT) Average Enterprise Value

How has AMYT Enterprise Value performed in the past?

The current Enterprise Value of Amryt Pharma plc (AMYT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

468.65M

5-year avg

302.91M

10-year avg

172.31M

Amryt Pharma plc (AMYT) Enterprise Value vs. Peers

How is AMYT’s Enterprise Value compared to its peers?

Amryt Pharma plc’s Enterprise Value is greater than Universe Pharmaceuticals INC (9.64M), greater than Regencell Bioscience Holdings Limited (66.70M), greater than Indigenous Bloom Hemp Corp. (518.77K), less than Eagle Pharmaceuticals, Inc. (116.66M), greater than Sangui Biotech International, Inc. (1.11M), greater than Qilian International Holding Group Limited (17.47M), greater than IM Cannabis Corp. (25.44M), less than GelStat Corporation (0), greater than Pacira BioSciences, Inc. (744.05K), less than Collegium Pharmaceutical, Inc. (1.83B), less than Prestige Consumer Healthcare Inc. (1.46B), less than Incannex Healthcare Limited (4.30B), greater than Phibro Animal Health Corporation (30.78M), less than Shuttle Pharmaceuticals Holdings, Inc. (1.22B), greater than Mallinckrodt plc (6.61M), less than Organogenesis Holdings Inc. (2.62B), less than Lucy Scientific Discovery Inc. (390.12M), greater than Alimera Sciences, Inc. (3.73M), less than null (225.55M),

Build a custom stock screener for Amryt Pharma plc (AMYT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amryt Pharma plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amryt Pharma plc (AMYT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amryt Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Amryt Pharma plc's Enterprise Value?

What is the highest Enterprise Value for Amryt Pharma plc (AMYT)?

What is the 3-year average Enterprise Value for Amryt Pharma plc (AMYT)?

What is the 5-year average Enterprise Value for Amryt Pharma plc (AMYT)?

How does the current Enterprise Value for Amryt Pharma plc (AMYT) compare to its historical average?